Results 131 to 140 of about 288,906 (308)

Sleep‐trackers in the wild: A faceted taxonomy for information and interaction design

open access: yesJournal of the Association for Information Science and Technology, EarlyView.
Abstract Consumer‐grade sleep‐tracking technologies (CSTs) have brought sleep into everyday data practices, reframing it from a clinical concern into a site of personal optimization and reflection. Yet existing taxonomies of sleep‐tracking often medicalize users and overlook the complexity of sleep‐tracking technologies. This paper presents SleepTax, a
Sanonda Datta Gupta   +2 more
wiley   +1 more source

Functional Brain Asymmetry Reveals Heterogeneous Subtypes in Autism Spectrum Disorder

open access: yesAutism Research, EarlyView.
ABSTRACT Heterogeneity is a critical factor in understanding inter‐individual brain and behavioral variability in autism spectrum disorder (ASD). Since individuals with ASD exhibit atypical communication and social interaction skills closely linked to brain lateralization, this study investigated ASD heterogeneity using an asymmetry index that captures
Chae Yeon Kim   +2 more
wiley   +1 more source

332. Kenji-kin

open access: yes, 1986
Iwao Seiichi, Iyanaga Teizō, Ishii Susumu, Yoshida Shōichirō, Fujimura Jun'ichirō, Fujimura Michio, Yoshikawa Itsuji, Akiyama Terukazu, Iyanaga Shōkichi, Matsubara Hideichi. 332. Kenji-kin. In: Dictionnaire historique du Japon, volume 12, 1986. Lettre K (
Iwao, Seiichi   +9 more
core  

The impact of curricular revision on student performance in pharmacology assessments

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims We implemented changes to a medical school curriculum aimed at boosting active learning and integrated instruction. Using the second level of Kirkpatrick's model, we describe the impact of the curricular revision on student performance in pharmacology assessments.
Erin R. Weeda, Kelly M. Quesnelle
wiley   +1 more source

Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle‐Aquitaine

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The French authorities mandated the use of secure prescriptions for pregabalin on May 2021. This study aimed to evaluate the impact of this measure on pregabalin use and misuse in Nouvelle‐Aquitaine, a southwestern French region with around six million inhabitants.
Maika Munech‐Herran   +5 more
wiley   +1 more source

332 S. Meyer

open access: yes, 1968
Rear view photograph of a large group of homes on S. Meyer, taken from the rear vacant lot. Cross streets, S. Meyer, W. Cushing.
Unknown
core  

Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga   +20 more
wiley   +1 more source

Assessment of the pregnancy outcome in women with first trimester bleeding [PDF]

open access: yesAl Ameen Journal of Medical Sciences
Introduction: First trimester bleeding is troublesome problem in pregnant women. It occurs due to various causes, some not related to pregnancy. It leads to various maternal & fetal adverse outcomes as well.
V. Sravani   +3 more
doaj  

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy